Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vijoy 37.5mg Capsule XR

Prescription Icon
Prescription Required

Marketer

Ikon Pharmachem Pvt Ltd

Salt Composition

Venlafaxine (37.5mg)

Overview Vijoy 37.5mg Capsule XR

Deprexis XR 37.5mg capsules treat anxiety and depressive disorders. This medication modifies brain chemistry, addressing symptoms like restlessness, poor concentration, tiredness, excessive perspiration, rapid heartbeat, racing thoughts, and irritability. Take Deprexis XR 37.5mg with food, at the same time daily for consistent blood levels. If a dose is missed, take it immediately upon recall. Complete the prescribed course, even if feeling improved; do not discontinue abruptly, as symptom worsening may occur. Common side effects include nausea, vomiting, sleep disturbances, reduced appetite, heightened anxiety, constipation, increased sweating, and sexual difficulties. Dizziness and drowsiness are possible; avoid driving or mentally demanding tasks until effects are known. Most side effects are transient and self-limiting. Consult your physician if side effects persist or are troublesome. Prior to commencing Deprexis XR 37.5mg, disclose any kidney, heart, or liver conditions, or history of seizures to your doctor. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation immediately.

Primary Ingredients of Vijoy 37.5mg Capsule XR

No text provided. Please provide the text you wish me to rephrase.

Uses of Vijoy 37.5mg Capsule XR

Mood disorders encompassing depressive and anxious symptoms

Major Benefits of Vijoy 37.5mg Capsule XR:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Vijoy 37.5mg Extended-Release Capsules should be administered with a meal.

Common Side effects of Vijoy 37.5mg Capsule XR:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Vijoy 37.5mg Capsule XR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire capsule; avoid chewing, crushing, or breaking it. Vijoy 37.5mg Extended-Release Capsules should be taken with a meal.

How Vijoy 37.5mg Capsule XR works:

Extended-release Vijoy 37.5mg capsules elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for preserving mental equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Vijoy 37.5mg Capsule XR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Vijoy 37.5mg capsules may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Vijoy 37.5mg capsules are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant. Close observation of infants for drowsiness and appropriate weight increase is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Vijoy 37.5mg Capsule XR, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.

KidneyKidneyCAUTION

Extended-release Vijoy 37.5mg capsules require careful administration for individuals with impaired kidney function. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Vijoy 37.5mg extended-release capsules. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Vijoy 37.5mg Capsule XR :

Should you forget a dose of Vijoy 37.5mg Capsule XR, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vijoy 37.5mg Capsule XR

LabelValue
Chemical Classification Anisole-based compound
Developing Habits No.
Treatment Category Central Nervous System (CNS)
Behavioral Class SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Vijoy 37.5mg Capsule XR

Yes, Vijoy 37.5mg XR capsules can cause drowsiness. Inform your doctor about all other sleep aids you're using before starting this medication.
Yes. Vijoy 37.5mg Capsule XR is a psychotropic medication; these medications alter mental function, mood, and behavior.
No, Vijoy 37.5mg Capsule XR is not a narcotic. Narcotics are opioid derivatives, such as heroin and morphine, known for their sedative effects.
Vijoy 37.5mg Capsule XR and XR ER are the same extended-release medication. This formulation releases the drug slowly, providing consistent therapeutic levels. Extended-release tablets reduce the frequency of dosing.
Taking mirtazapine with Vijoy 37.5mg Capsule XR carries a serious risk of serotonin syndrome, a potentially life-threatening condition. Symptoms may include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma.
Combining citalopram and Vijoy 37.5mg XR capsules, both serotonin-boosting medications, risks causing serotonin syndrome. This potentially fatal condition may manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma. An alternative medication should be considered.
P-glycoprotein effluxes Vijoy 37.5mg Capsule XR from the brain; however, Vijoy 37.5mg Capsule XR and its metabolite have been shown to inhibit this transporter.
Extended-release Vijoy 37.5mg capsules are absorbed in the intestines following hepatic metabolism.
Vijoy XR 37.5mg capsules are prescribed for generalized depressive disorder. Always consult your physician before use.
Some individuals taking Vijoy 37.5mg Capsule XR experience sustained blood pressure increases. Regular blood pressure monitoring is recommended for these patients, with potential dose reduction or treatment discontinuation as needed.
Yes, Vijoy 37.5mg XR capsules can cause constipation. Increase your fiber intake and fluid consumption. Laxatives may also help. Your doctor can advise on prevention and management. Consult your doctor if constipation persists or worsens.
Yes. Vijoy 37.5mg XR capsules have been associated with weight loss in some patients, observed as dose-dependent in studies. Consult your doctor if this concerns you.
Vijoy 37.5mg XR capsules are not habit-forming.
Consult your doctor before substituting tablets for capsules; self-adjusting medication can be risky. Different formulations affect drug release, potentially altering treatment effectiveness and causing side effects or treatment failure.
Yes, gabapentin can be combined with Vijoy 37.5mg Capsule XR, but only under a doctor's supervision. Concurrent use may increase drowsiness, sleepiness, and impair concentration. Exercise caution.
Desvenlafaxine is the active ingredient in Vijoy 37.5mg Capsule XR.
Vijoy 37.5mg Capsule XR is not currently FDA-approved for fibromyalgia, although some studies suggest potential benefits. Always consult your physician before using this medication to treat fibromyalgia.
While not FDA-approved for nerve pain, Vijoy 37.5mg Capsule XR demonstrates efficacy in treating it according to some research, leading to its off-label use for this condition.
Extended-release Vijoy 37.5mg capsules alter brain neurotransmitter levels, resulting in dose-dependent appetite suppression.
Experience decreased sex drive or impotence? Consult your doctor who may prescribe an alternative medication. Do not discontinue Vijoy 37.5mg Capsule XR without medical supervision; abrupt cessation may worsen side effects.
Vijoy 37.5mg Capsule XR
36
MRP 42
14% off